Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Follow-up Study of BRL-101 for TDT
Sponsor: Bioray Laboratories
Summary
Observe long-term safety risk and long-term efficacy after intravenous infusion of BRL-101 in TDT subjects.
Official title: Long-term Follow-up Study of BRL-101 in the Treatment of Transfusion-dependent β-thalassemia
Key Details
Gender
All
Age Range
3 Years - 35 Years
Study Type
OBSERVATIONAL
Enrollment
45
Start Date
2024-12-08
Completion Date
2038-10-15
Last Updated
2024-03-22
Healthy Volunteers
No
Conditions
Interventions
Assessments
Safety and efficacy assessments
Locations (7)
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China
Shenzhen Children 's Hospital
Shenzhen, Guangdong, China
No. 923 Hospital of Joint Support Force of Chinese People 's Liberation Army Hospital
Nanning, Guangxi, China
Xiangya Hospital of Central South University
Changsha, Hunan, China
Tianjin Institute of Hematology
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital of GUANGXI MEDICAL UNIVERSITY
Guangxi, China